Vascular Flow Technologies (VFT) has announced the successful conclusion of a strategic intellectual property out-licencing agreement with Biovic Sdn bhd.
Bayer and its cooperation partner Janssen Research & Development have announced two publications of further data from the Phase III COMPASS study in The Lancet, one in patients with peripheral artery disease (PAD) and the other in patients with coronary artery disease (CAD).
Getinge has installed the 1,000th hybrid operating room (OR) worldwide. West Virginia University (WVU) Heart and Vascular Institute, in Morgantown, USA, has installed three new, state-of-the-art hybrid ORs. Designed for patients requiring vascular or structural heart procedures, Hybrid ORs combine a traditional operating room with a catheterisation lab and imaging suite.
InspireMD has announced it has signed Diverse Devices as its exclusive distributor for Australia and New Zealand, and has signed Do Gia Production and Trading JSC as its exclusive distributor in Vietnam. The company’s product line includes the Cguard embolic prevention system (EPS).
Following a fenestrated endovascular aneurysm repair (FEVAR), the infrarenal aortic neck often continues to dilate. At the 2017 VEITHsymposium, Benjamin Starnes (University of Washington, Seattle, USA) suggested that such dilation is harmful when observed in standard EVAR practised outside instructions for use (IFU) or in association with a hostile neck. However, Starnes said that aortic neck dilation is harmless when observed with FEVAR, and that “less device oversizing may be acceptable given long seal zone lengths”.
The use of surgical simulators is important to assess competence, plan complex cases and develop skills, but they “do not replace clinical and surgical experience,” according to José Fernandes e Fernandes (Lisbon Academic Medical Centre and Lisbon Cardiovascular Institute, Lisbon, Portugal), who spoke at the 2017 VEITHsymposium (14–18 November, New York, USA).
Janssen has submitted a supplemental new drug application to the US Food and Drug Administration (FDA) for two new Xarelto (rivaroxaban) vascular indications: reducing the risk of major cardiovascular (CV) events such as CV death, heart attack or stroke in patients with chronic coronary and/or peripheral artery disease (CAD/PAD), and for reducing the risk of acute limb ischaemia in patients with PAD.
Merit Medical has announced signing an asset purchase agreement with BD (Becton, Dickinson and company) to acquire certain assets which BD proposes to sell in connection with its proposed acquisition of CR Bard. Merit’s proposed asset acquisition is subject to the closing of BD’s proposed acquisition of Bard as well as other usual and customary closing conditions.
Terumo has announced that it has launched QuiremSpheres microspheres in Europe on 18 September.
TVA Medical’s everlinQ 4 endovascular arteriovenous fistula (AVF) system has received CE mark in the European Union. The technology uses a 4F catheter system with enhanced visual indicators to create haemodialysis access using an endovascular technique without open surgery.
The US Food and Drug Administration has cleared Adhezion Biomedical’s SecurePortIV catheter securement adhesive for marketing.
BTG has highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th annual scientific sessions (14–17 June, New Orleans USA). The study found chronic deep vein thrombosis patients with post-thrombotic syndrome can be treated safely and effectively with Ekos therapy.
Adept Medical, the Auckland based manufacturer of the STARSystem, has announced the release of its latest product innovation, the I.R. Platform (interventional radiology platform). The I.R. Platform is an over-the-patient work surface, specifically designed for use by interventional radiologists when they are working through the femoral artery.
Argon Medical announced in June that it has formalised a Medical Advisory Board comprised of distinguished physicians from institutions across the USA who specialise in interventional medicine. The Medical Advisory Board will continue to provide scientific and clinical expertise to guide the organisation in planning and implementing product development initiatives and marketing programs with the goal of improving the lives of patients and their caregivers, a press release from the company states.
The ASTER randomised clinical trial that examined the effect of endovascular contact aspiration vs. stent retriever on revascularisation in patients with acute ischaemic stroke and large vessel occlusion in the anterior circulation found that first-line thrombectomy with contact aspiration compared with stent retriever did not result in an increased successful revascularisation rate at the end of the procedure.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos